Skip to content

Assessment of clinical availability for one-on-one phone support Program in capecitabine together with oxaliplatin (CapeOx) as adjuvant chemotherapy in patient with Stage III Colon Cancer; Multi-center Observation study.

Assessment of clinical availability for one-on-one phone support Program in capecitabine together with oxaliplatin (CapeOx) as adjuvant chemotherapy in patient with Stage III Colon Cancer; Multi-center Observation study. - EXTENSION Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000007856
Enrollment
55
Registered
2012-05-01
Start date
2011-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

StageIII colon cancer

Interventions

None listed

Sponsors

Division of Gastroenterological Surgery, Toho University Omori Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Histological confirmation of colorectal cancer with curative resection (2) Patients Who scheduled to receive capecitabine together with oxaliplatin (CapeOx) treatment. (3) Written informed consent. (4) 20 years old or more when received informed consent. (5) Eastern Cooperative Oncology Group (ECOG) performance status (PS) : 0 - 1. (6) Patients who received no previous chemotherapy or radiotherapy treatment. (7)Patients with oral intake is possible

Exclusion criteria

Exclusion criteria: (1)Patient condition corresponds with section of contraindication or contraindication in combination for the administration of Capecitabine and Oxaliplatin. (2)Not appropriate for the study at the physician's assessment.

Design outcomes

Primary

MeasureTime frame
Hand-Foot Syndrome (> grade 3) events rate.

Secondary

MeasureTime frame
Completion rate. Evaluation of QOL(Skin Toxicity - Related symptoms) 3-year Relapse-free survival. Compliance. Relative dose intensity. Duration of a call. Patient satisfaction for phone support Program. Number of all outpatient visits. Number of phone times for Unscheduled. Number of phone times after the Fourth course.

Countries

Japan

Contacts

Public ContactJunichi Koike

Toho University Omori Medical Center Division of Gastroenterological Surgery

jkoike18@med.toho-u.ac.jp03-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026